# Body Mass Index a Forecast of Sputum Culture Conversion Among Drug-Resistant Tuberculosis Patients

**Authors:** Amaan Latif, R.A.S. Kushwaha, Gaurav Srivastava, Ankit Kumar, Surya Kant, Satish Kumar

PMC · DOI: 10.7759/cureus.63262 · Cureus · 2024-06-27

## TL;DR

Low body mass index is linked to slower sputum culture conversion in drug-resistant tuberculosis patients.

## Contribution

This study identifies BMI as an independent risk factor for delayed sputum culture conversion in drug-resistant TB patients.

## Key findings

- Patients with BMI <18.5 had a 46% sputum culture conversion rate versus 60% for those with BMI ≥18.5.
- 26% of low-BMI patients remained sputum-positive after three months compared to 8% in higher-BMI patients.
- Low BMI was an independent risk factor for poor sputum culture conversion in drug-resistant TB.

## Abstract

Background

Drug-resistant tuberculosis is a major health issue around the world. The time it takes to find a sputum-positive patient is a major risk factor for the spread of tuberculosis, and many things can indicate a longer time to culture conversion. Also, there is strong proof that poor nutrition is linked to infectious diseases. So, this study aimed to look into the link between a person's body mass index (BMI) and the change of a sputum culture within three months in people who have rifampicin-resistant (RR)/multidrug-resistant (MDR)-tuberculosis (TB) kept on a bedaquiline-based regimen.

Materials and methods

The Department of Respiratory Medicine at King George's Medical University, Lucknow, hosted an observational, analytical, prospective, single-center study from May 2020 to April 2021. The study included 105 people who had been identified with RR/MDR-TB and were on an optimized background regimen that included a bedaquiline-based regimen. The result we were interested in was sputum culture conversion within three months, and we looked at how BMI related to that outcome. Analytical analyses utilized Pearson’s chi-square test for categorical variables and the t-test for continuous variables. Differences with a P-value of <0.05 were considered significant. SPSS software (version 18.0, IBM Corp., Armonk, NY, USA) was used for all analyses, with missing data not replaced or credited.

Results

A total of 105 people who met the inclusion and exclusion criteria were analyzed. The patients had a mean age of 33.34 years and were mostly male 61 (58%). Fifty-eight (58; 55%) patients lived in rural areas. Most patients had fever 77 (73%), cough 72 (69%), and weight loss 66 (63%). Sixty-nine (69; 66%) patients had a history of TB. Fifty-seven patients had a BMI of <18.5 kg/m2, and 48 patients had with BMI of ≥18.5. At the end of the study, 75/105 patients converted their sputum culture. Of the 105 patients, 57 (54%) had a low BMI (less than 18.5 kg/m2). Among the 57 patients with a BMI of <18.5 kg/m2, only 28 (46%) achieved sputum culture conversion after 3 months while 29 (60%) of 48 with BMI ≥18.5 achieved sputum culture conversion after 3 months. Among the patients with a BMI <18.5, 15/57 (26%) tested positive for sputum culture after three months. In patients with a BMI of ≥18.5, only 4/48 (8%) patients tested positive for sputum culture after three months.

Conclusion

In patients with drug-resistant tuberculosis, low BMI (<18.5 kg/m2) was an independent risk factor for failing to convert sputum cultures within three months.

## Linked entities

- **Diseases:** tuberculosis (MONDO:0018076), drug-resistant tuberculosis (MONDO:0041806), rifampicin-resistant tuberculosis (MONDO:0100479), multidrug-resistant tuberculosis (MONDO:0005861)

## Full-text entities

- **Diseases:** weight loss (MESH:D015431), infectious diseases (MESH:D003141), Drug-Resistant Tuberculosis (MESH:D018088), cough (MESH:D003371), TB (MESH:D014376), fever (MESH:D005334)
- **Chemicals:** rifampicin (MESH:D012293), bedaquiline (MESH:C493870)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11282479/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC11282479/full.md

---
Source: https://tomesphere.com/paper/PMC11282479